Q1 2025 Supplemental Financial Information Table of Contents

Non-GAAP Financial Measures

1

Condensed Consolidated Statements of Operations - Fiscal Quarters

2

Condensed Consolidated Balance Sheets

3

Condensed Consolidated Statements of Cash Flows - Fiscal Quarters

4

Reconciliation of GAAP to Non-GAAP Measures - Fiscal Quarters

5

‌Non-GAAP Financial Measures

This supplemental financial information contains financial statements that have not been prepared in accordance with generally accepted accounting principles in the United States (GAAP). We use these non-GAAP financial measures and other key metrics internally to facilitate analysis of our financial and business trends and for internal planning and forecasting purposes. We believe these non-GAAP financial measures, when taken collectively, may be helpful to investors because they provide consistency and comparability with past financial performance by excluding certain items that may not be indicative of our business, results of operations, or outlook. However, non-GAAP financial measures have limitations as an analytical tool and are presented for supplemental informational purposes only. They should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.

A reconciliation of our non-GAAP financial measures to the most directly comparable GAAP measures has been provided in the financial statement tables included in this supplemental financial information, and investors are encouraged to review these reconciliations.

‌Confluent, Inc. Condensed Consolidated Statements of Operations - Fiscal Quarters (in thousands, except percentages, share and per share data) (unaudited)

Three Months Ended

Q2'23

Q3'23

Q4'23

Q1'24

Q2'24

Q3'24

Q4'24

Q1'25

Revenue:

Subscription

$

176,488

$

189,270

$

202,787

$

206,902

$

224,702

$

239,851

$

250,636

$

260,910

Services

12,797

10,911

10,397

10,335

10,284

10,348

10,584

10,210

Total revenue

189,285

200,181

213,184

217,237

234,986

250,199

261,220

271,120

Cost of revenue:

Subscription

44,188

44,104

44,807

48,355

52,863

52,162

55,220

56,847

Services

13,732

12,445

12,250

12,866

12,118

11,541

12,345

12,271

Total cost of revenue

57,920

56,549

57,057

61,221

64,981

63,703

67,565

69,118

Gross profit

131,365

143,632

156,127

156,016

170,005

186,496

193,655

202,002

Subscription

75.0%

76.7%

77.9%

76.6%

76.5%

78.3%

78.0%

78.2%

Services

(7.3%)

(14.1%)

(17.8%)

(24.5%)

(17.8%)

(11.5%)

(16.6%)

(20.2%)

Total gross margin

69.4%

71.8%

73.2%

71.8%

72.3%

74.5%

74.1%

74.5%

Operating expenses:

Research and development

85,677

91,237

86,948

97,571

106,060

102,720

114,886

116,801

Sales and marketing

127,770

128,624

119,911

131,352

132,865

137,968

145,194

146,259

General and administrative

36,343

31,874

33,948

38,444

39,429

39,471

39,359

40,120

Restructuring and other related charges

943

529

-

-

-

-

-

-

Total operating expenses

250,733

252,264

240,807

267,367

278,354

280,159

299,439

303,180

Operating loss

(119,368

)

(108,632

)

(84,680

)

(111,351

)

(108,349

)

(93,663

)

(105,784

)

(101,178

)

Other income, net

17,610

17,529

21,775

20,850

21,853

22,495

19,288

20,410

Loss before income taxes

(101,758

)

(91,103

)

(62,905

)

(90,501

)

(86,496

)

(71,168

)

(86,496

)

(80,768

)

Provision for (benefit from) income taxes

1,667

1,567

31,191

2,466

3,404

2,976

1,558

(13,194

)

Net loss

$

(103,425

)

$

(92,670

)

$

(94,096

)

$

(92,967

)

$

(89,900

)

$

(74,144

)

$

(88,054

)

$

(67,574

)

Net loss per share, basic and diluted

$

(0.35

)

$

(0.30

)

$

(0.30

)

$

(0.30

)

$

(0.28

)

$

(0.23

)

$

(0.27

)

$

(0.20

)

Weighted-average shares used to

compute net loss per share, basic and diluted

297,827,200

303,896,632

309,101,119

314,203,181

319,415,586

324,317,971

329,406,849

335,755,902

‌Confluent, Inc. Condensed Consolidated Balance Sheets

(in thousands) (unaudited)

March 31,

December 31,

2025

2024

ASSETS

Current assets:

Cash and cash equivalents

$

278,561

$

385,980

Marketable securities

1,638,016

1,524,583

Accounts receivable, net

297,862

314,306

Deferred contract acquisition costs

46,149

47,271

Prepaid expenses and other current assets

82,250

79,179

Total current assets

2,342,838

2,351,319

Property and equipment, net

81,697

78,680

Operating lease right-of-use assets

7,923

8,818

Goodwill

164,406

164,406

Intangible assets, net

7,463

7,924

Deferred contract acquisition costs, non-current

69,069

71,468

Other assets, non-current

25,278

12,296

Total assets

$

2,698,674

$

2,694,911

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable

$

5,983

$

7,531

Accrued expenses and other liabilities

141,922

194,250

Operating lease liabilities

9,093

8,694

Deferred revenue

372,870

378,771

Total current liabilities

529,868

589,246

Operating lease liabilities, non-current

6,735

9,138

Deferred revenue, non-current

32,511

30,430

Convertible senior notes, net

1,093,094

1,092,149

Other liabilities, non-current

11,133

12,722

Total liabilities

1,673,341

1,733,685

Stockholders' equity:

Preferred stock

-

-

Class A common stock

2

2

Class B common stock

1

1

Additional paid-in capital

3,079,260

2,953,080

Accumulated other comprehensive income (loss)

2,860

(2,641

)

Accumulated deficit

(2,056,790

)

(1,989,216

)

Total stockholders' equity

1,025,333

961,226

Total liabilities and stockholders' equity

$

2,698,674

$

2,694,911

‌Confluent, Inc. Condensed Consolidated Statements of Cash Flows - Fiscal Quarters

(in thousands) (unaudited)

Three Months Ended

Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss $ (103,425 )

$ (92,670 )

$ (94,096 )

$ (92,967 )

$ (89,900 )

$ (74,144 )

$ (88,054 )

$ (67,574 )

Adjustments to reconcile net loss to cash (used in) provided by operating activities:

Depreciation and amortization

3,256

3,609

3,923

4,311

5,842

5,702

6,234

6,605

Net accretion of discounts on marketable securities

(10,588 )

(11,300 )

(11,484 )

(10,396 )

(9,871 )

(9,294 )

(8,205 )

(6,847 )

Amortization of debt issuance costs

950

961

963

953

953

964

966

945

Amortization of deferred contract acquisition costs

11,053

11,923

12,428

12,762

13,334

13,949

14,213

13,931

Non-cash operating lease costs

977

934

874

885

969

940

1,172

1,075

Stock-based compensation, net of amounts capitalized

92,159

89,514

88,871

95,322

99,107

98,307

102,924

92,575

Deferred income taxes

5

15

1,864

615

(273 )

(111 )

46

(17,338 )

Other

572

2,263

(756 )

849

361

485

1,675

454

Changes in operating assets and liabilities, net of effects of business combinations:

Accounts receivable

(19,361 )

5,153

(47,453 )

29,360

(58,018 )

(21,577 )

(36,327 )

15,414

Deferred contract acquisition costs

(13,806 )

(15,607 )

(21,781 )

(9,732 )

(15,296 )

(12,244 )

(15,974 )

(10,410 )

Prepaid expenses and other assets

(9,198 )

(7,768 )

3,438

(1,929 )

3,703

(2,135 )

1,205

1,515

Accounts payable

(7,395 )

(488 )

4,756

(4,932 )

11,987

1,231

(8,159 )

(1,274 )

Accrued expenses and other liabilities

24,109

10,413

43,368

(43,752 )

46,893

(10,363 )

32,861

(49,828 )

Operating lease liabilities

(1,756 )

(1,808 )

(1,917 )

(1,935 )

(1,994 )

(2,020 )

(4,191 )

(2,177 )

Deferred revenue

3,388

(4,204 )

29,237

(5,368 )

793

25,923

34,825

(3,820 )

Net cash (used in) provided by operating activities

(29,060 )

(9,060 )

12,235

(25,954 )

8,590

15,613

35,211

(26,754 )

CASH FLOWS FROM INVESTING ACTIVITIES

Capitalization of internal-use software costs

(5,330 )

(3,660 )

(4,299 )

(5,539 )

(4,776 )

(5,669 )

(5,420 )

(4,806 )

Purchases of marketable securities

(546,408 )

(235,824 )

(351,105 )

(443,307 )

(455,883 )

(273,169 )

(367,357 )

(405,235 )

Sales of marketable securities

-

-

-

-

12,744

-

2,567

-

Maturities of marketable securities

523,606

228,328

374,612

432,267

403,489

374,281

381,127

299,467

Purchases of investments in privately-held companies

-

-

-

-

(1,000 )

(1,250 )

-

-

Purchases of property and equipment

(809 )

(363 )

(1,116 )

(186 )

(1,105 )

(607 )

(669 )

(1,429 )

Cash paid for business combinations, net of cash acquired

-

-

(10,000 )

-

-

(115,516 )

-

-

Net cash (used in) provided by investing activities

(28,941 )

(11,519 )

8,092

(16,765 )

(46,531 )

(21,930 )

10,248

(112,003 )

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from issuance of common stock upon exercise of vested options

27,492

14,673

10,974

14,401

13,096

8,835

19,504 16,606

Repurchases of unvested common stock

-

(32 )

-

-

-

-

- -

Proceeds from issuance of common stock under employee stock purchase plan

-

11,536

-

15,603

-

8,367

- 14,195

Net cash provided by financing activities

27,492

26,177

10,974

30,004

13,096

17,202

19,504

30,801

Effect of exchange rate changes on cash and cash equivalents

(308 )

(1,198 )

1,417

(673 )

(200 )

393

(1,589 )

537

Net (decrease) increase in cash and cash equivalents

(30,817 )

4,400

32,718

(13,388 )

(25,045 )

11,278

63,374

(107,419 )

Cash and cash equivalents at beginning of period

343,460

312,643

317,043

349,761

336,373

311,328

322,606

385,980

Cash and cash equivalents at end of period

$ 312,643

$ 317,043

$ 349,761

$ 336,373

$ 311,328

$ 322,606

$ 385,980

$ 278,561

‌Confluent, Inc. Reconciliation of GAAP to Non-GAAP Measures - Fiscal Quarters (in thousands, except percentages, share and per share data) (unaudited)

Three Months Ended

Q2'23

Q3'23

Q4'23

Q1'24

Q2'24

Q3'24

Q4'24

Q1'25

Reconciliation of GAAP total gross profit to non-GAAP total gross profit:

Total gross profit on a GAAP basis

$

131,365

$

143,632

$

156,127

$

156,016

$

170,005

$

186,496

$

193,655

$

202,002

Total gross margin on a GAAP basis

69.4%

71.8%

73.2%

71.8%

72.3%

74.5%

74.1%

74.5%

Add: Stock-based compensation-related charges(1)

10,432

9,095

8,932

10,623

11,630

11,340

11,626

10,575

Add: Amortization of acquired intangibles

127

129

195

502

501

585

780

461

Non-GAAP total gross profit

$

141,924

$

152,856

$

165,254

$

167,141

$

182,136

$

198,421

$

206,061

$

213,038

Non-GAAP total gross margin

75.0%

76.4%

77.5%

76.9%

77.5%

79.3%

78.9%

78.6%

Reconciliation of GAAP subscription gross profit to non-GAAP subscription gross profit:

Subscription gross profit on a GAAP basis

$

132,300

$

145,166

$

157,980

$

158,547

$

171,839

$

187,689

$

195,416

$

204,063

Subscription gross margin on a GAAP basis

75.0%

76.7%

77.9%

76.6%

76.5%

78.3%

78.0%

78.2%

Add: Stock-based compensation-related charges(1)

7,179

6,350

6,309

7,905

9,292

8,999

9,242

8,708

Add: Amortization of acquired intangibles

127

129

195

502

501

585

780

461

Non-GAAP subscription gross profit

$

139,606

$

151,645

$

164,484

$

166,954

$

181,632

$

197,273

$

205,438

$

213,232

Non-GAAP subscription gross margin

79.1%

80.1%

81.1%

80.7%

80.8%

82.2%

82.0%

81.7%

Three Months Ended

Q2'23

Q3'23

Q4'23

Q1'24

Q2'24

Q3'24

Q4'24

Q1'25

Reconciliation of GAAP operating expenses to non-GAAP operating expenses:

Research and development operating expense on a GAAP basis

$

85,677

$

91,237

$

86,948

$

97,571

$

106,060

$

102,720

$

114,886

$

116,801

Research and development operating expense as a

percentage of total revenue on a GAAP basis

45.3%

45.6%

40.8%

44.9%

45.1%

41.1%

44.0%

43.1%

Less: Stock-based compensation-related charges(1)

36,726

38,464

36,972

41,424

41,866

42,259

45,938

43,835

Less: Acquisition-related expenses

3,841

3,841

3,841

4,362

4,472

5,870

10,046

9,641

Non-GAAP research and development operating expense

$

45,110

$

48,932

$

46,135

$

51,785

$

59,722

$

54,591

$

58,902

$

63,325

Non-GAAP research and

development operating expense as a percentage of total revenue

23.8%

24.4%

21.6%

23.8%

25.4%

21.8%

22.5%

23.4%

Sales and marketing operating expense on a GAAP basis

$

127,770

$

128,624

$

119,911

$

131,352

$

132,865

$

137,968

$

145,194

$

146,259

Sales and marketing operating expense as a percentage of total revenue on a GAAP basis

67.5%

64.3%

56.2%

60.5%

56.5%

55.1%

55.6%

53.9%

Less: Stock-based compensation-related charges(1)

34,377

33,095

31,406

35,780

35,332

33,639

35,178

32,757

Less: Acquisition-related expenses

1,076

1,076

1,076

-

-

-

717

1,076

Non-GAAP sales and marketing operating expense

$

92,317

$

94,453

$

87,429

$

95,572

$

97,533

$

104,329

$

109,299

$

112,426

Non-GAAP sales and marketing operating expense as a percentage

of total revenue

48.8%

47.2%

41.0%

44.0%

41.5%

41.7%

41.8%

41.5%

General and administrative operating expense on a GAAP basis

$

36,343

$

31,874

$

33,948

$

38,444

$

39,429

$

39,471

$

39,359

$

40,120

General and administrative operating expense as a percentage of total revenue on a

GAAP basis

19.2%

15.9%

15.9%

17.7%

16.8%

15.8%

15.1%

14.8%

Less: Stock-based compensation-related charges(1)

14,223

11,333

12,857

15,158

15,872

14,599

14,837

14,410

Less: Acquisition-related expenses

281

148

650

225

6

1,169

302

14

Non-GAAP general and administrative operating expense

$

21,839

$

20,393

$

20,441

$

23,061

$

23,551

$

23,703

$

24,220

$

25,696

Non-GAAP general and

administrative operating expense as a percentage of total revenue

11.5%

10.2%

9.6%

10.6%

10.0%

9.5%

9.3%

9.5%

Three Months Ended

Q2'23

Q3'23

Q4'23

Q1'24

Q2'24

Q3'24

Q4'24

Q1'25

Reconciliation of GAAP operating loss to non-GAAP operating (loss) income:

Operating loss on a GAAP basis

$

(119,368

)

$

(108,632

)

$

(84,680

)

$

(111,351

)

$

(108,349

)

$

(93,663

)

$

(105,784

)

$

(101,178

)

GAAP operating margin

(63.1%)

(54.3%)

(39.7%)

(51.3%)

(46.1%)

(37.4%)

(40.5%)

(37.3%)

Add: Stock-based compensation-related charges(1)

95,758

91,987

90,167

102,985

104,700

101,837

107,579

101,577

Add: Amortization of acquired intangibles

127

129

195

502

501

585

780

461

Add: Acquisition-related expenses

5,198

5,065

5,567

4,587

4,478

7,039

11,065

10,731

Add: Restructuring and other related charges

943

529

-

-

-

-

-

-

Non-GAAP operating (loss) income

$

(17,342

)

$

(10,922

)

$

11,249

$

(3,277

)

$

1,330

$

15,798

$

13,640

$

11,591

Non-GAAP operating margin

(9.2%)

(5.5%)

5.3%

(1.5%)

0.6%

6.3%

5.2%

4.3%

Reconciliation of GAAP net loss to non-GAAP net income:

Net loss on a GAAP basis

$

(103,425

)

$

(92,670

)

$

(94,096

)

$

(92,967

)

$

(89,900

)

$

(74,144

)

$

(88,054

)

$

(67,574

)

Add: Stock-based compensation-related charges(1)

95,758

91,987

90,167

102,985

104,700

101,837

107,579

101,577

Add: Amortization of acquired intangibles

127

129

195

502

501

585

780

461

Add: Acquisition-related expenses

5,198

5,065

5,567

4,587

4,478

7,039

11,065

10,731

Add: Restructuring and other related charges

943

529

-

-

-

-

-

-

Add: Amortization of debt issuance costs

950

961

963

953

953

964

966

945

Add: Income tax effects and adjustments(2)(3)

507

328

29,373

(260

)

(175

)

(1,529

)

(1,272

)

(17,156

)

Non-GAAP net income

$

58

$

6,329

$

32,169

$

15,800

$

20,557

$

34,752

$

31,064

$

28,984

Non-GAAP net income per share, basic

$

0.00

$

0.02

$

0.10

$

0.05

$

0.06

$

0.11

$

0.09

$

0.09

Non-GAAP net income per share, diluted

$

0.00

$

0.02

$

0.09

$

0.05

$

0.06

$

0.10

$

0.09

$

0.08

Weighted-average shares used to

compute non-GAAP net income per share, basic

297,827,200

303,896,632

309,101,119

314,203,181

319,415,586

324,317,971

329,406,849

335,755,902

Weighted-average shares used to

compute non-GAAP net income per share, diluted

339,296,142

346,974,638

342,370,878

350,195,868

354,236,764

353,577,179

362,149,550

367,802,218

(1)Represents stock-based compensation expense, employer taxes on employee stock transactions, and amortization of stock-based compensation capitalized in internal-use software. We began excluding amortization of stock-based compensation capitalized in internal-use software from our non-GAAP measures starting with the quarter ended March 31, 2024. The amounts of amortization of stock-based compensation capitalized in internal-use software were immaterial in both current and prior periods.

(2)Income tax effects and adjustments for the three months ended December 31, 2023 primarily consists of income tax expense related to an intra-group transfer of acquired intellectual property.

(3)Income tax effects and adjustments for the three months ended March 31, 2025 includes an adjustment for the income tax benefit from the release of a valuation allowance on certain deferred tax asset.

Three Months Ended

Q2'23

Q3'23

Q4'23

Q1'24

Q2'24

Q3'24

Q4'24

Q1'25

Net cash (used in) provided by operating activities

$

(29,060

)

$

(9,060

)

$

12,235

$

(25,954

)

$

8,590

$

15,613

$

35,211

$

(26,754

)

Capitalized internal-use software costs

(5,330

)

(3,660

)

(4,299

)

(5,539

)

(4,776

)

(5,669

)

(5,420

)

(4,806

)

Capital expenditures

(809

)

(363

)

(1,116

)

(186

)

(1,105

)

(607

)

(669

)

(1,429

)

Free cash flow

$

(35,199

)

$

(13,083

)

$

6,820

$

(31,679

)

$

2,709

$

9,337

$

29,122

$

(32,989

)

Impact from compensation payments adjustment(1)

-

-

-

-

-

-

-

37,930

Adjusted free cash flow

$

(35,199

)

$

(13,083

)

$

6,820

$

(31,679

)

$

2,709

$

9,337

$

29,122

$

4,941

Net cash (used in) provided by operating activities as a

percentage of total revenue

(15.4%)

(4.5%)

5.7%

(11.9%)

3.7%

6.2%

13.5%

(9.9%)

Free cash flow margin

(18.6%)

(6.5%)

3.2%

(14.6%)

1.2%

3.7%

11.1%

(12.2%)

Adjusted free cash flow margin

(18.6%)

(6.5%)

3.2%

(14.6%)

1.2%

3.7%

11.1%

1.8%

Net cash (used in) provided by investing activities

$

(28,941

)

$

(11,519

)

$

8,092

$

(16,765

)

$

(46,531

)

$

(21,930

)

$

10,248

$

(112,003

)

Net cash provided by financing activities

$

27,492

$

26,177

$

10,974

$

30,004

$

13,096

$

17,202

$

19,504

$

30,801

(1)Represents an adjustment to reflect the non-recurring impact in the first quarter of 2025 from the change to timing of cash compensation payments for most of our non go-to-market employees implemented at the start of 2025.

Remaining Performance Obligations ("RPO")

RPO represent the amount of contracted future revenue that has not yet been recognized as of the end of each period, including both deferred revenue that has been invoiced and non-cancelable committed amounts that will be invoiced and recognized as revenue in future periods. RPO exclude pay-as-you-go arrangements. As of March 31, 2025, the Company's RPO was $1,016.1 million, approximately 61% of which is expected to be recognized as revenue over the next 12 months and the substantial majority of the remainder in the next 13 to 36 months. Actual amounts or timing of revenue recognized may differ due to subsequent contract modifications.

Attachments

  • Original document
  • Permalink

Disclaimer

Confluent Inc. published this content on April 30, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 30, 2025 at 20:11 UTC.